Chemical engineers find that arrays of carbon nanotubes can detect flaws in drugs and help improve production
MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs — especially those based on antibodies — more safely and efficiently.
Using these sensors, the researchers were able to characterize variations in the binding strength of antibody drugs, which hold promise for treating cancer and other diseases. They also used the sensors to monitor the structure of antibody molecules, including whether they contain a chain of sugars that interferes with proper function.
“This could help pharmaceutical companies figure out why certain drug formulations work better than others, and may help improve their effectiveness,” says Michael Strano, an MIT professor of chemical engineering and senior author of a recent paper describing the sensors in the journal ACS Nano.
The team also demonstrated how nanosensor arrays could be used to determine which cells in a population of genetically engineered, drug-producing cells are the most productive or desirable, Strano says.
Lead author of the paper is Nigel Reuel, a graduate student in Strano’s lab. The labs of MIT faculty members Krystyn Van Vliet, Christopher Love and Dane Wittrup also contributed, along with scientists from Novartis.
Testing drug strength
Strano and other scientists have previously shown that tiny, nanometer-sized sensors, such as carbon nanotubes, offer a powerful way to detect minute quantities of a substance. Carbon nanotubes are 50,000 times thinner than a human hair, and they can bind to proteins that recognize a specific target molecule. When the target is present, it alters the fluorescent signal produced by the nanotube in a way that scientists can detect.
Some researchers are trying to exploit large arrays of nanosensors, such as carbon nanotubes or semiconducting nanowires, each customized for a different target molecule, to detect many different targets at once. In the new study, Strano and his colleagues wanted to explore unique properties that emerge from large arrays of sensors that all detect the same thing.
The first feature they discovered, through mathematical modeling and experimentation, is that uniform arrays can measure the distribution in binding strength of complex proteins such as antibodies. Antibodies are naturally occurring molecules that play a key role in the body’s ability to recognize and defend against foreign invaders. In recent years, scientists have been developing antibodies to treat disease, particularly cancer. When those antibodies bind to proteins found on cancer cells, they stimulate the body’s own immune system to attack the tumor.
For antibody drugs to be effective, they must strongly bind their target. However, the manufacturing process, which relies on nonhuman, engineered cells, does not always generate consistent, uniformly binding batches of antibodies.
Currently, drug companies use time-consuming and expensive analytical processes to test each batch and make sure it meets the regulatory standards for effectiveness. However, the new MIT sensor could make this process much faster, allowing researchers to not only better monitor and control production, but also to fine-tune the manufacturing process to generate a more consistent product.
“You could use the technology to reject batches, but ideally you’d want to use it in your upstream process development to better define culture conditions, so then you wouldn’t produce spurious lots,” Reuel says.
Measuring weak interactions
Another useful trait of such sensors is their ability to measure very weak binding interactions, which could also help with antibody drug manufacturing.
The Latest Bing News on:
- Gate-tunable van der Waals heterostructure for reconfigurable neural network vision sensoron June 24, 2020 at 1:55 pm
Early processing of visual information takes place in the human retina. Mimicking neurobiological structures and functionalities of the retina provides a promising pathway to achieving vision sensor ...
- Solid semiconductor sensor cooled with laseron June 24, 2020 at 5:54 am
This took less than 1ms and lasted for as long as the laser was being used. This was the first-ever demonstration of solid-state laser cooling of nanoscale sensors. “Historically, the laser heating of ...
- Laser allows solid-state refrigeration of a semiconductor materialon June 23, 2020 at 1:36 pm
But that laser also heats the cantilever, which dampens its performance. "Historically, the laser heating of nanoscale devices was a major problem that was swept under the rug," said senior author ...
- Solid-State Laser Refrigeration of Nanoscale Sensors Achieved – Could Revolutionize Bio-Imaging and Quantum Communicationon June 23, 2020 at 1:02 pm
To the general public, lasers heat objects. And generally, that would be correct. But lasers also show promise to do quite the opposite — to cool materials. Lasers that can cool materials could ...
- Solid-State LiDAR Leverages Liquid-Crystal Metasurfaces, CMOS Manufacturingon June 22, 2020 at 2:27 pm
The commercially viable silicon beamsteering system provides a scalable platform for automotive, consumer, and industrial use cases.
- Critical communications component made on a flexible wooden filmon June 22, 2020 at 7:24 am
Madison engineer leverages a surprising and inexpensive substance — wood — to make the flexible microwave circuits that power modern communications.
- Polymers can fine-tune attractions between suspended nanocubeson June 19, 2020 at 1:35 pm
Researchers demonstrate a high level of control over a type of colloid in which the suspended particles take the form of hollow, nanoscale cubes. This case has only previously been explored through ...
- A deep-learned E-skin decodes complex human motionon June 18, 2020 at 6:29 am
A deep-learning powered single-strained electronic skin sensor can capture human motion from a distance. The single strain sensor placed on the wrist decodes complex five-finger motions in real time ...
- 5 Stocks to Tap the Nanotechnology Market Boomon June 16, 2020 at 6:37 am
Nanotechnology has revolutionized multiple fields, starting from computers to healthcare and even military. Technology innovation is being conducted at nanoscale and it offers myriad opportunities for ...
The Latest Google Headlines on:
The Latest Bing News on:
- Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nationson June 29, 2020 at 8:21 pm
Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the ...
- UCSD Joins Network To Examine Mexican Opioid Productionon June 29, 2020 at 7:59 pm
The University of California San Diego announced Monday its Center for U.S.-Mexican Studies will be a major partner in the new Mexico Opium Network, an international effort to examine the ...
- Roche Gets FDA OK for Injectable Version of Breast Cancer Drugon June 29, 2020 at 7:19 pm
A new version of a combination drug marketed by Roche for early-stage and metastatic breast cancer with a specific genetic signature received FDA approval ...
- Gilead Fixes the Price of COVID-19 Drug Remdesivir; the Government Secures the Bulk of Its Supplyon June 29, 2020 at 7:12 pm
Remdesivir, a malaria drug that has been repurposed to treat COVID-19 and currently represents the best hope for attacking the disease, now has a price tag. On Monday, the company behind the ...
- Deputies seize drugs, guns, homemade bombs at Lexington County homeon June 29, 2020 at 6:42 pm
Lexington County deputies seized about $30,000 worth of drugs along with explosive devices last week during an investigation into drug and gun activity. Based on information gathered during an ...
- Deputies seize drugs, guns, and homemade bombs from Lexington homeon June 29, 2020 at 5:46 pm
The Lexington County Sheriff’s Department has seized around $30,000 worth of drugs along with explosive devices during an investigation last week.
- The cost of COVID-19 drug remdesivir: $2,340 to $3,120 per patienton June 29, 2020 at 5:23 pm
Gilead Sciences, the manufacturer of an experimental antiviral drug used to shorten the effects of the COVID-19 disease, announced on Monday costs for remdesivir, which it claims is far below how ...
- Fresh Express bagged salads recalled after more than 200 illnesses reportedon June 29, 2020 at 4:08 pm
The salad mixes contain iceberg lettuce, red cabbage and carrot ingredients and are marked with the letter "Z" at the beginning of the product code.
- Gilead’s Price for Drug to Treat Coronavirus Sparks Affordability Questions, Concernson June 29, 2020 at 3:33 pm
Remdesivir will cost $2,340 for a five-day course in all developed countries except the U.S., where it will cost $3,120 for the typical patient with private insurance, Gilead Sciences announced on ...
- Muscle Relaxants Drugs Market Size, Share, Trends, Application, Production, Manufacturer and Industry Report Analysis 2025on June 29, 2020 at 1:53 am
Manhattan, New York, Analytical Research Cognizance: The global Muscle Relaxants Drugs market size is expected ...